About us
Sai Parenterals Limited is a diversified pharmaceutical formulations company with expertise in research, development, and manufacturing. We operate across two business verticals
Our portfolio spans multiple therapeutic areas including cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals & supplements (VMS), analgesics, and dermatology. We manufacture products across dosage forms such as injectables, tablets, capsules, liquid orals, and ointments, developed through in-house R&D and strategic acquisitions.
In the injectables segment, we have sterile manufacturing capabilities for critical care and penicillin-based therapies, with delivery systems including dry powder injections, pre-filled syringes, ampoules, and vials.
We serve a diverse domestic customer base, including central and state government agencies, pharmaceutical companies, institutions, and super stockists. In Fiscal 2023, we expanded into exports after acquiring two internationally accredited facilities in Hyderabad, Telangana. Today, we export to regulated and semi-regulated markets in Australia, New Zealand, Southeast Asia, the Middle East, and Africa.
Our CDMO business vertical provides end-to-end solutions covering product development, regulatory dossier preparation, international filings, validation batches, and commercial manufacturing.
We have four (4) Manufacturing Facilities based in Hyderabad, Telangana, including two dedicated to injectables, a solid oral dosage facility, and a dedicated cephalosporin facility. One of these Manufacturing Facilities is approved by TGA-Australia, two are WHO GMP approved, and one is a GMP facility. Additionally, we operate one (1) GMP facility in Ongole, Andhra Pradesh, through our wholly owned subsidiary, Revat Laboratories Private Limited (“Revat”).
Our Manufacturing Facilities have a combined installed capacity of 1,160 million units per annum on a single shift basis. Our manufacturing capabilities encompass the production of generic and complex generic products, developed and produced in strict adherence to current Good Manufacturing Practices (cGMP).
